Particulate endocytosis mediates biological responses of human mesenchymal stem cells to titanium wear debris.
Continual loading and articulation cycles undergone by metallic (e.g., titanium) alloy arthroplasty prostheses lead to liberation of a large number of metallic debris particulates, which have long been implicated as a primary cause of periprosthetic osteolysis and postarthroplasty aseptic implant loosening. Long-term stability of total joint replacement prostheses relies on proper integration between implant biomaterial and osseous tissue, and factors that interfere with this integration are likely to cause osteolysis. Because multipotent mesenchymal stem cells (MSCs) located adjacent to the implant have an osteoprogenitor function and are critical contributors to osseous tissue integrity, when their functions or activities are compromised, osteolysis will most likely occur. To date, it is not certain or sufficiently confirmed whether MSCs endocytose titanium particles, and if so, whether particulate endocytosis has any effect on cellular responses to wear debris. This study seeks to clarify the phenomenon of titanium endocytosis by human MSCs (hMSCs), and investigates the influence of endocytosis on their activities. hMSCs incubated with commercially pure titanium particles exhibited internalized particles, as observed by scanning electron microscopy and confocal laser scanning microscopy, with time-dependent reduction in the number of extracellular particles. Particulate endocytosis was associated with reduced rates of cellular proliferation and cell-substrate adhesion, suppressed osteogenic differentiation, and increased rate of apoptosis. These cellular effects of exposure to titanium particles were reduced when endocytosis was inhibited by treatment with cytochalasin D, and no significant effect was seen when hMSCs were treated only with conditioned medium obtained from particulate-treated cells. These findings strongly suggest that the biological responses of hMSCs to wear debris are triggered primarily by the direct endocytosis of titanium particulates, and not mediated by secreted soluble factors. In this manner, therapeutical approaches that suppress particle endocytosis could reduce the bioreactivity of hMSCs to particulates, and enhance long-term orthopedic implant prognosis by minimizing wear-debris periprosthethic osteolysis.
Okafor
Chukwuka C
CC
Cartilage Biology and Orthopaedics Branch, National Institutes of Arthritis, and Musculoskeletal and Skin Diseases, National Institutes of Health, Building 50, Room 1503, MSC8022, Department of Health and Human Services, Bethesda, Maryland 20892-8022, USA.
Haleem-Smith
Hana
H
Laqueriere
Patrice
P
Manner
Paul A
PA
Tuan
Rocky S
RS
D017209:Apoptosis / Q000187:drug effects; D019643:Arthroplasty, Replacement / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods; D002448:Cell Adhesion / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D015638:Cytochalasin D / Q000494:pharmacology; D004705:Endocytosis / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D007595:Joint Prosthesis / Q000009:adverse effects*; D059630:Mesenchymal Stem Cells / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D018613:Microscopy, Confocal; D010012:Osteogenesis / Q000187:drug effects; D010014:Osteolysis; D014025:Titanium / Q000009:adverse effects* / Q000378:metabolism
D015638:Cytochalasin D; D014025:Titanium